We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$17.9B
AUM Growth
+$3.18B
Cap. Flow
+$2.11B
Cap. Flow %
11.82%
Top 10 Hldgs %
38.29%
Holding
721
New
293
Increased
98
Reduced
124
Closed
140

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$124M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$95.2M
3
PLRX icon
Pliant Therapeutics
PLRX
+$74.8M
4
MSFT icon
Microsoft
MSFT
+$72.6M
5
BMY icon
Bristol-Myers Squibb
BMY
+$56.6M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$123M
2
CTLT
CATALENT, INC.
CTLT
+$60.4M
3
EMR icon
Emerson Electric
EMR
+$55M
4
HD icon
Home Depot
HD
+$54.8M
5
CMCSA icon
Comcast
CMCSA
+$53.9M

Sector Composition

Rank Sector Weight
1 Healthcare 5.44%
2 Technology 2.51%
3 Communication Services 1.69%
4 Utilities 1.38%
5 Industrials 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPT
551
DELISTED
Opthea Limited American Depositary Shares
OPT
$63.4K ﹤0.01%
22,652
– –
CMRX
552
DELISTED
Chimerix, Inc.
CMRX
$61.5K ﹤0.01%
+50,800
New +$64.4K
NOTV
553
DELISTED
Inotiv
NOTV
$61.1K ﹤0.01%
+12,807
New +$70.7K
KNTE
554
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$60.8K ﹤0.01%
+20,075
New +$77.4K
VXRT
555
DELISTED
Vaxart
VXRT
$59K ﹤0.01%
+80,843
New +$75.1K
APEI icon
556
American Public Education
APEI
$940M
$52.9K ﹤0.01%
+11,165
New +$60.8K
OCGN icon
557
Ocugen
OCGN
$434M
$52.7K ﹤0.01%
97,016
+47,238
+95% +$30.3K
LL
558
DELISTED
LL Flooring Holdings, Inc.
LL
$52.7K ﹤0.01%
+13,756
New +$53.2K
AXP icon
559
PUT
American Express
AXP
$230B
$52.3K ﹤0.01%
+300
New +$48.4K
INO icon
560
Inovio Pharmaceuticals
INO
$69M
$51.8K ﹤0.01%
+9,660
New +$77.9K
HAL icon
561
Halliburton
HAL
$26.6B
$49.8K ﹤0.01%
+1,511
New +$47.7K
AFMD
562
DELISTED
Affimed
AFMD
$49.8K ﹤0.01%
+8,322
New +$66.7K
ESPR
563
DELISTED
Esperion Therapeutics
ESPR
$48.9K ﹤0.01%
+35,146
New +$49.1K
NKTR icon
564
Nektar Therapeutics
NKTR
$2.58B
$48.7K ﹤0.01%
+5,650
New +$60.2K
DBTX
565
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$46.2K ﹤0.01%
11,990
– –
FFAI
566
Faraday Future Intelligent Electric
FFAI
$10.5M
– –
0
– –
ZS icon
567
PUT
Zscaler
ZS
$27.3B
$43.9K ﹤0.01%
+300
New +$36.6K
USB icon
568
PUT
US Bancorp
USB
$99.6B
$39.6K ﹤0.01%
+1,200
New +$38.8K
RAD
569
DELISTED
Rite Aid Corporation
RAD
$39K ﹤0.01%
+25,848
New +$51.8K
NAMSW icon
570
NewAmsterdam Pharma Warrant
NAMSW
$78.2M
$34.8K ﹤0.01%
16,666
– –
TBLAW
571
DELISTED
Taboola.com Ltd Warrant
TBLAW
$33.9K ﹤0.01%
85,000
– –
LENZ
572
LENZ Therapeutics
LENZ
$168M
$31.7K ﹤0.01%
1,743
-70,128
-98% -$1.4M
THC icon
573
Tenet Healthcare
THC
$21.1B
$19.7K ﹤0.01%
+242
New +$17.2K
MAR icon
574
CALL
Marriott International
MAR
$92.3B
$18.4K ﹤0.01%
+100
New +$17.3K
MAR icon
575
PUT
Marriott International
MAR
$92.3B
$18.4K ﹤0.01%
+100
New +$17.3K
21 22
23
24 25

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Laurion Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Laurion Capital Management held 721 positions worth $17.9B, up 22% from $14.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Laurion Capital Management deployed $2.11B of net new capital in Q2 2023, opening 293 new positions and adding to 98 existing holdings. Its largest new stake was Pliant Therapeutics: 3,158,570 shares worth $57.2M.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 6.6% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Viatris, an estimated $123M trimmed.

  • Laurion Capital Management's largest Q2 2023 buy was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
  • Laurion Capital Management added most to T-Mobile US in Q2 2023, an estimated $124M increase.
  • Laurion Capital Management's biggest Q2 2023 reduction was Viatris, cutting an estimated $123M.
  • Laurion Capital Management fully exited CATALENT, INC. in Q2 2023, selling an estimated $60.4M.
  • Laurion Capital Management's ten largest holdings make up 38% of its $17.9B portfolio in Q2 2023.
  • Laurion Capital Management opened 293 new positions and closed 140 in Q2 2023.
  • Laurion Capital Management's portfolio value rose 22% quarter-over-quarter to $17.9B.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.